Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTissue Regenix Group Regulatory News (TRX)

  • This share is currently suspended. It was suspended at a price of 7.23
  • There is currently no data for TRX

AGM Statement

25 May 2006 07:04

Torex Retail PLC25 May 2006 25 May 2006 Torex Retail Plc AGM STATEMENT Torex Retail ("Torex Retail" or "the Group"), an international market leader inthe provision of innovative retail IT systems, will today hold its AnnualGeneral Meeting. Chris Moore, Chairman and Chief Executive, will make thefollowing statement on current trading: The Group has made a good start to the year enjoying sales success in all ourkey business areas and geographic markets. In addition to the £30 million of newcontracts that we secured in the first quarter, the Group has continued to winsignificant contracts with new and existing customers including McDonald's,Boots, Liz Claiborne, BT, Tesco, Walmart-Asda and the Dutch Post Office. Particularly pleasing was a contract with The Picture People, a US portraitstudio chain with over 300 outlets nationwide. This was our first new businesswin for our Lucas EPoS product from a US headquartered retailer and was achievedwithin a year of the launch of this product into the US market. The system willstart roll out in July and will be a valuable reference site for further salesprogress in the US. Integration of 2005 acquisitions has continued to plan and we have now agreedformal employment plans with our employees in Germany. As a result, plans arenow being implemented to reduce the workforce by approximately 150 employees,with restructuring costs and subsequent annualised savings in line with theoriginal estimates previously communicated to the Stock Market. In April we completed the US$55 million acquisition of Savista, whichrepresented a major strategic step in the development of our Group and itsfurther penetration of the US market. Torex Retail is now the global EPoSsupplier to McDonalds and a market leader in the Quick Service Restaurantsector, the fastest growing part of the hospitality market. We see tremendousopportunities for this business going forward both from increased sales toMcDonalds and new business wins from other international QSR chains and alsothrough indirect channel sales. Trading for the first quarter was in line with our budget and the continuedlevel of order intake gives the Board confidence that the first six months of2006 will meet expectations. As in previous years, we expect trading activity toincrease in the second six months of 2006. Based on our current order book andsales pipeline, we are confident of achieving the full year forecastexpectations currently in the Stock Market. Chris Moore, Chairman and Chief Executive of Torex Retail, commented: "I am delighted with the progress we have made this year to date. The continuingprogramme of integrating our acquisitions is delivering bottom line savings andoperating efficiencies at the same time as we continue to target top linegrowth. Last year saw us become the leading provider of retail IT systems across Europeand we believe 2006 will see us make significant steps towards becoming aleading supplier to the North American market as well as further strengtheningour market position and brand on the global stage. The continuing delivery of the company strategy is both exciting and representsfurther consolidation of delivering shareholder value". - ends - For further information please contact: Torex RetailChris Moore, Chairman and Chief Executive +44 (0)870 300 6061 Citigate Dewe RogersonGinny Pulbrook, Executive Director +44 (0)20 7282 2945Seb Hoyle, Associate Director +44 (0)20 7282 2822 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
30th Mar 20207:00 amRNSUpdate in relation to working capital position
20th Mar 20207:00 amRNSDirectorate Change
6th Feb 20207:15 amEQSHardman & Co Research: Tissue Regenix (TRX): Restructured to satisfy product demand
4th Feb 202011:47 amRNSResolution of Cyber Security Incident
28th Jan 202010:02 amRNSNotice of cyber security incident
22nd Jan 20207:00 amRNSTrading Update
14th Jan 20204:40 pmRNSSecond Price Monitoring Extn
14th Jan 20204:35 pmRNSPrice Monitoring Extension
21st Nov 20194:35 pmRNSPrice Monitoring Extension
18th Nov 20194:03 pmRNSDirectorate Change
14th Nov 20194:00 pmRNSHolding(s) in Company
14th Nov 20197:00 amRNSUpdated loan facility agreement with MidCap
13th Nov 20193:35 pmRNSHolding(s) in Company
13th Nov 20193:17 pmRNSHolding(s) in Company
11th Nov 20192:05 pmRNSSecond Price Monitoring Extn
11th Nov 20192:00 pmRNSPrice Monitoring Extension
11th Nov 20197:00 amRNSUpdate in relation to loan facility
17th Oct 20194:27 pmRNSHolding(s) in Company
17th Oct 20197:00 amRNSTrading Update
15th Oct 20193:27 pmRNSHolding(s) in Company
3rd Oct 20197:00 amRNSDermaPure Product Line Extension Launched
10th Sep 20197:00 amRNSUnaudited Interim Results
28th Aug 20197:00 amRNSAppointment of CFO
15th Aug 20197:00 amRNSAdditional manufacturing capacity secured
1st Aug 20197:00 amRNSDirectorate Change
8th Jul 20195:03 pmRNSHolding(s) in Company
20th Jun 20192:23 pmEQSHardman & Co Research: Tissue Regenix (TRX): Credit facilities expand cash runway to 2021
7th Jun 20192:55 pmRNSIssue of Equity and Total Voting Rights
4th Jun 20197:00 amRNSNotice of AGM
4th Jun 20197:00 amRNSSecures Credit Facilities of up to $20m
4th Jun 20197:00 amRNSAnnual Results for the year ended 31 December 2018
21st May 20197:00 amRNSCEO to return to full time duties
10th Apr 20197:20 amEQSHardman & Co Research: Tissue Regenix (TRX): Expanded GPO coverage secured
4th Apr 20197:26 amRNSExpands US GPO coverage for DermaPure
18th Feb 20197:00 amRNSChange of Adviser
6th Feb 201911:05 amRNSSecond Price Monitoring Extn
6th Feb 201911:00 amRNSPrice Monitoring Extension
4th Feb 20197:00 amRNSTrading Update
17th Dec 201811:56 amEQSHardman & Co Research: Tissue Regenix (TRX): 2018 in review: foundations laid for osteobiologics
6th Dec 20187:00 amRNSInterim Management Change
13th Nov 20187:00 amRNSPan European distribution agreement with Arthrex
29th Oct 20187:00 amRNSGareth Jones commences position as CFO
14th Sep 20187:16 amEQSHardman & Co Research: Tissue Regenix (TRX): Strategy delivering growth above expectations
3rd Sep 20187:00 amRNSUnaudited Interim Results
2nd Aug 201810:10 amEQSHardman & Co Research: Tissue Regenix (TRX): 1H'18 preview: organic plus inorganic growth
2nd Aug 20187:00 amRNSNotice of Interim Results
4th Jul 20187:00 amRNSAppointment of CFO
25th Jun 20187:00 amRNSHTA License granted and UK distribution Agreement
21st Jun 20187:10 amRNSTRX BioSurgery wins GPO Supplier Horizon Award
18th Jun 20187:00 amRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.